Literature DB >> 9068888

Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

H Sahli1, J Tapon-Bretaudière, A M Fischer, C Sternberg, G Spenlehauer, T Verrecchia, D Labarre.   

Abstract

When surfactant-stabilized biodegradable poly(lactic acid) (PLA) particles are injected into rats, the rate of clearance from blood is fast. The rate can be strongly reduced by using particles made from diblock copolymers of PLA and poly(ethylene oxide) (PLA-PEO), resulting in an increased duration of contact with the components of the coagulation system. Thus, possible adverse effects such as activation of the coagulation cascade could occur. In this paper, the interactions of surfactant-stabilized PLA and PLA-PEO nanoparticle suspensions with the plasma factors of the coagulation system are presented. PLA suspensions stabilized by sodium cholate (PLA-Ch) interact with thrombin, factor V and calcium ions. Formation of complexes and aggregates is induced by addition of calcium ions to PLA-Ch suspensions in the presence or in the absence of plasma. On the contrary, PLA-PEO suspensions are remarkably inert towards the coagulation factors and calcium ions, even when cholate is present. Steric repulsion owing to the high surface density of PEO is sufficient to avoid strong interations with the proteins and formation of aggregates between particles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9068888     DOI: 10.1016/s0142-9612(96)00146-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Intravenous hemostat: nanotechnology to halt bleeding.

Authors:  James P Bertram; Cicely A Williams; Rebecca Robinson; Steven S Segal; Nolan T Flynn; Erin B Lavik
Journal:  Sci Transl Med       Date:  2009-12-16       Impact factor: 17.956

3.  Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

Authors:  Isabelle Bertholon; Christine Vauthier; Denis Labarre
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

4.  Synthesis of pegylated immunonanoparticles.

Authors:  Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

5.  Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).

Authors:  C Passirani; G Barratt; J P Devissaguet; D Labarre
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

6.  CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility.

Authors:  Stephen P Samuel; Maria J Santos-Martinez; Carlos Medina; Namrata Jain; Marek W Radomski; Adriele Prina-Mello; Yuri Volkov
Journal:  Int J Nanomedicine       Date:  2015-04-02

Review 7.  Nanoparticles from renewable polymers.

Authors:  Frederik R Wurm; Clemens K Weiss
Journal:  Front Chem       Date:  2014-07-18       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.